Daratumumab, Pomalidomide and Dexamethasone (DPd) in Relapsed/ Refractory Light Chain Amyloidosis Previously Exposed to Daratumumab
Rosenbaum, Cara, Liedtke, Michaela, Christos, Paul, Kim, Hyemin, Pogonowski, Kathleen, Agudo, Natalie, Barroso, Bruna, Shelton, Anthony, Reilly, Samantha, Gadbois, Courtney, Sloan, John Mark, Sanchorawala, Vaishali, D'Souza, Anita
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Daratumumab in Patients with Multiple Myeloma and Renal Impairment - Real-World Data from a Single-Center Institution
Monge, Jorge, Solomon, Robin S., Flicker, Kari, Jayabalan, David S, Guo, Jin, Contreras, Jorge, Pogonowski, Kathleen, Agudo, Natalie, Guarneri, Danielle, Liotta, Brielle, Lopes, Eloisi Caldas, Pearse, Roger, Coleman, Morton, Niesvizky, Ruben, Rossi, Adriana C.
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article
A Phase 1/2 Study to Assess Safety and Dose of Ixazomib in Combination with Cyclophosphamide and Dexamethasone in Newly Diagnosed Patients with Light Chain (AL) Amyloidosis
Sanchez, Larysa, Landau, Heather J, Rosenbaum, Cara A., Abrahams, Alex, Chin, Cindy, Liotta, Brielle, Agudo, Natalie, Ramnath, Sheetal, Hoover, Elizabeth, Rahman, Hafsa, Ozbek, Umut, Lahoud, Oscar B, Hassoun, Hani, Osman, Keren
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article
Comparison of Early Versus Delayed Filgrastim (G-CSF) Administration Following Autologous Stem Cell Transplantation in Patients with Multiple Myeloma - Real-World Data from a Single-Center Institution
Monge, Jorge, Flicker, Kari, Guarneri, Danielle, Solomon, Robin S., Guo, Jin, Contreras, Jorge, Agudo, Natalie, Jayabalan, David S, Pogonowski, Kathleen, Liotta, Brielle, Hsu, Jingmei, Phillips, Adrienne A., Mayer, Sebastian A., Gergis, Usama, Shore, Tsiporah B., Van Besien, Koen, Coleman, Morton, Rosenbaum, Cara A., Pearse, Roger, Rossi, Adriana C., Niesvizky, Ruben
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article
A phase 1/2 study to assess safety and dose of ixazomib in combination with cyclophosphamide and dexamethasone in newly diagnosed patients with light chain (AL) amyloidosis
Sanchez, Larysa, Landau, Heather, Rosenbaum, Cara, Abrahams, Alex, Chin, Cindy, Liotta, Brielle, Agudo, Natalie, Ramnath, Sheetal, Hoover, Elizabeth, Rahman, Hafsa, Ozbek, Umut, Lahoud, Oscar, Hassoun, Hani, Osman, Keren
Published in Clinical lymphoma, myeloma and leukemia (01.10.2019)
Published in Clinical lymphoma, myeloma and leukemia (01.10.2019)
Get full text
Journal Article